Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis

BACKGROUND: Preoperative treatment of anti-vascular endothelial growth factor (VEGF) agents is extensively used in proliferative diabetic retinopathy (PDR), but the molecular mechanism is not fully understood. The objective of this research is to observe change of protein profile induced by ranibizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Chen, Han, Changjing, Zhao, Minjie, Yu, Jingjing, Bai, Lin, Yao, Yuan, Gao, Shuaixin, Cao, Hui, Zheng, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844103/
https://www.ncbi.nlm.nih.gov/pubmed/29541006
http://dx.doi.org/10.1186/s12014-018-9187-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844103/
https://www.ncbi.nlm.nih.gov/pubmed/29541006
http://dx.doi.org/10.1186/s12014-018-9187-z

Ejemplares similares